← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 4,260

Funds Holding Change -19

Funds Holding Growth -0.4%

Value $894B

Holding in Top 10 754

Top 10 Change +230

Top 10 Growth +44%

Value Growth +1%

New 152

Increased 1,817

Reduced 1,973

Closed 114

Capital Inflow $37.3B

Capital Outflow $25.1B

Net Capital Flow +$12.2B

Capital Flow Change +$14.6B

Calls $9.58B

Puts $10.2B

Net Calls -$643M

Put/Call Ratio 1.07